-
CT-Guided Thrombectomy for Large Core Stroke Up to 24 Hours-Another Piece in a Complex Puzzle. JAMA (IF 63.1) Pub Date : 2024-09-23 Jane Khalife,Daniel A Tonetti,Tudor G Jovin
-
The US Preventive Services Task Force in Legal Jeopardy JAMA (IF 63.1) Pub Date : 2024-09-23 Christopher Robertson, Kirsten Bibbins-Domingo, Gregory Curfman
This work discusses the Braidwood Management Inc v Becerra case and how the intent of Congress, the health of the public, and the law may come into conflict.
-
Preventive Care Coverage Threatened by Federal Court Ruling JAMA (IF 63.1) Pub Date : 2024-09-23 Carmel Shachar, Elizabeth Kaplan
This Viewpoint highlights the 2 most concerning aspects of the Braidwood Management Inc v Becerra ruling and their potential effect on health equity.
-
Health Care Actions for Reducing Plastic Use and Pollution JAMA (IF 63.1) Pub Date : 2024-09-23 Hilary Ong, Cassandra L. Thiel, Hardeep Singh
This Viewpoint proposes a comprehensive sociotechnical approach spanning the entire plastics life cycle to reduce plastic use and pollution in health care.
-
The US Presidential Election’s High Stakes for the Future of Medicine JAMA (IF 63.1) Pub Date : 2024-09-20 Nicole Huberfeld, Elizabeth McCuskey, Michael R. Ulrich
This Viewpoint examines how the outcome of the 2024 US presidential election could affect the future of medicine and public health, particularly the antimedicine proposals found in the Republican Party’s Project 2025 playbook.
-
Diversity Action Plans in Clinical Trials JAMA (IF 63.1) Pub Date : 2024-09-20 Rebecca K. Metcalfe, Jay J. H. Park
This Viewpoint discusses the US Food and Drug Administration’s upcoming mandate on diversity actions plans for trial sponsors and the importance of developing accountability mechanisms to monitor those plans.
-
The Promise and Perils of Diversity Action Plans for Clinical Trials JAMA (IF 63.1) Pub Date : 2024-09-20 Tanvee Varma, Barbara E. Bierer, Andrew Hantel
This Viewpoint discusses the US Food and Drug Administration’s authority to require drug and device sponsors to submit diversity action plans and policy gaps that limit the organization’s ability to achieve demographic representation in clinical trials.
-
Action Needed to Ease Parental Stress, US Surgeon General Warns. JAMA (IF 63.1) Pub Date : 2024-09-20 Samantha Anderer
-
Risk Factors for Immune Checkpoint Inhibitor-Induced Diabetes Identified. JAMA (IF 63.1) Pub Date : 2024-09-20 Samantha Anderer
-
Hormone Therapy Associated With Slower Biological Aging in Menopause. JAMA (IF 63.1) Pub Date : 2024-09-20 Samantha Anderer
-
What to Know About the Recent Rise in Parvovirus B19 Infections JAMA (IF 63.1) Pub Date : 2024-09-20 Rita Rubin
This Medical News article discusses the recent increase in parvovirus B19 infections in the US, resulting in a health advisory from the Centers for Disease Control and Prevention.
-
WHO Announces Mpox Global Plan, Appeals for Funding. JAMA (IF 63.1) Pub Date : 2024-09-20 Samantha Anderer
-
HHS Dedicates Millions to Expand Prenatal, Postpartum Home Visits. JAMA (IF 63.1) Pub Date : 2024-09-20 Samantha Anderer
-
Study: Heat-Related Deaths on the Rise in US Since 2016. JAMA (IF 63.1) Pub Date : 2024-09-20 Samantha Anderer
-
FDA Approves First Automated Insulin Device for Type 2 Diabetes. JAMA (IF 63.1) Pub Date : 2024-09-20 Samantha Anderer
-
Risk Stratification in Nonischemic Dilated Cardiomyopathy Using CMR Imaging JAMA (IF 63.1) Pub Date : 2024-09-19 Christian Eichhorn, David Koeckerling, Rohin K. Reddy, Maddalena Ardissino, Marek Rogowski, Bernadette Coles, Lukas Hunziker, Simon Greulich, Isaac Shiri, Norbert Frey, Jens Eckstein, Stephan Windecker, Raymond Y. Kwong, George C. M. Siontis, Christoph Gräni
ImportanceAccurate risk stratification of nonischemic dilated cardiomyopathy (NIDCM) remains challenging.ObjectiveTo evaluate the association of cardiac magnetic resonance (CMR) imaging–derived measurements with clinical outcomes in NIDCM.Data SourcesMEDLINE, Embase, Cochrane Library, and Web of Science Core Collection databases were systematically searched for articles from January 2005 to April 2023
-
Discovery of cGAS as a DNA-Sensing Enzyme That Triggers Inflammation JAMA (IF 63.1) Pub Date : 2024-09-19 Zhijian J. Chen
In this Viewpoint, 2024 Albert Lasker Basic Medical Research Award winner Zhijian J. Chen describes his discovery of cyclic guanosine monophosphate–adenosine monophosphate synthase (cGAS), a DNA-sensing enzyme that triggers inflammation.
-
Speed Limits JAMA (IF 63.1) Pub Date : 2024-09-19 Eleanor R. Menzin
In this narrative medicine essay, a pediatrician discusses the ambiguity of diagnoses of patients and settles on honestly admitting when the parameters are unclear with an explanation of the range of possibilities.
-
Chemistry Matters—From a Putative Peptide to Effective Treatments for Diabetes and Obesity JAMA (IF 63.1) Pub Date : 2024-09-19 Svetlana Mojsov
In this Viewpoint, 2024 Lasker-DeBakey Clinical Medical Research Award winner Svetlana Mojsov describes her discovery of GLP-1 (7-37), the biologically active incretin that led to development of effective GLP-1 analogues for treating diabetes and obesity.
-
GLP-1 for Treating Obesity—Origin, History, and Evolution JAMA (IF 63.1) Pub Date : 2024-09-19 Lotte Bjerre Knudsen
In this Viewpoint, 2024 Lasker-DeBakey Clinical Medical Research Award winner Lotte Bjerre Knudsen describes her discovery of glucagon-like peptide-1 for the treatment of patients with obesity.
-
Thirty-Five Years of HIV Research in Africa—An Interview With Winners of the 2024 Lasker-Bloomberg Public Service Award JAMA (IF 63.1) Pub Date : 2024-09-19 Preeti Malani
This Medical News article is an interview with Quarraisha Abdool Karim, PhD, and Salim S. Abdool Karim, MBChB, PhD, who received the award for their decades of work on AIDS in Africa.
-
AIDS in Africa—Impact of Research JAMA (IF 63.1) Pub Date : 2024-09-19 Quarraisha Abdool Karim, Salim S. Abdool Karim
In this Viewpoint, 2024 Lasker-Bloomberg Public Service Award winners Quarraisha Abdool Karim and Salim S. Abdool Karim discuss their journey in AIDS research in South Africa and the local and global health impact of this research.
-
The Science of Biosimilars—Updating Interchangeability JAMA (IF 63.1) Pub Date : 2024-09-18 Patrizia Cavazzoni, Sarah Yim
This Viewpoint from the US Food and Drug Administration (FDA) summarizes a recent update to an FDA draft interchangeability guidance regarding the need for clinical switching studies to illustrate the FDA’s ongoing efforts to streamline the development of biosimilar medications that are in line with the latest science.
-
The Patent Trial and Appeals Board JAMA (IF 63.1) Pub Date : 2024-09-18 Janet Freilich, Aaron S. Kesselheim
This Viewpoint summarizes the role of the Patent Trial and Appeal Board (PTAB) in reforming the drug patent process to avoid erroneously granted patents; highlights how other reform efforts, such as the PREVAIL Act, actually weaken the PTAB; and suggests changes to strengthen the PTAB and promote generic availability and reduced health care costs.
-
Word Choice and the Patient Encounter JAMA (IF 63.1) Pub Date : 2024-09-18 Jeffrey D. Robinson, Douglas J. Opel
This JAMA Insights in the Communicating Medicine series explores how differences in word choice can affect both visit interactions and visit outcomes in patient encounters.
-
The Crucial Role of Rapid Point-of-Care Tests for Malaria in Improving Fever Management. JAMA (IF 63.1) Pub Date : 2024-09-18 Osondu Ogbuoji,Wendy Prudhomme O'Meara
-
Characteristics and Trends of Prehospital Encounters for Opioid Overdoses Among US Youth, 2018-2022 JAMA (IF 63.1) Pub Date : 2024-09-18 Jamie K. Lim, Sriram Ramgopal, Jennifer A. Hoffmann, Doug Lorenz, Michael S. Toce
This cross-sectional study analyzes characteristics of prehospital encounters for youth opioid overdoses and trends before and during the COVID-19 pandemic.
-
Malaria Rapid Tests, Febrile Illness Management, and Child Mortality Across Sub-Saharan African Countries JAMA (IF 63.1) Pub Date : 2024-09-18 Han Zhang, Günther Fink, Jessica Cohen
ImportanceA prompt malaria diagnosis is crucial for the management of children with febrile illness in sub-Saharan African countries, where malaria remains a leading cause of mortality among children younger than 5 years of age. The development and distribution of point-of-care rapid diagnostic tests (RDTs) for malaria has transformed practice, but limited systematic evidence exists on how malaria
-
Community-Acquired Pneumonia JAMA (IF 63.1) Pub Date : 2024-09-16 Valerie M. Vaughn, Robert P. Dickson, Jennifer K. Horowitz, Scott A. Flanders
ImportanceCommunity-acquired pneumonia (CAP) results in approximately 1.4 million emergency department visits, 740 000 hospitalizations, and 41 000 deaths in the US annually.ObservationsCommunity-acquired pneumonia can be diagnosed in a patient with 2 or more signs (eg, temperature >38 °C or ≤36 °C; leukocyte count <4000/μL or >10 000/μL) or symptoms (eg, new or increased cough or dyspnea)
-
Fetal Personhood Laws and Their Implications for Health Care JAMA (IF 63.1) Pub Date : 2024-09-16 Carmel Shachar, Lucy Tu, Bhav Jain
This Viewpoint explores the various types of state laws establishing fetal personhood and the potential implications of these laws on health care, patients, and clinicians.
-
The Supreme Court and the Emergency Medical Treatment and Labor Act—A Dangerous Time for Us All JAMA (IF 63.1) Pub Date : 2024-09-16 Michele B. Goodwin, Allison M. Whelan, Lawrence O. Gostin
This Viewpoint explores recent US Supreme Court decisions and how they threaten the Emergency Medical Treatment and Labor Act and the health, safety, and rights of pregnant persons throughout the country.
-
Effect of High-Intensity vs Low-Intensity Noninvasive Positive Pressure Ventilation on the Need for Endotracheal Intubation in Patients With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease: The HAPPEN Randomized Clinical Trial. JAMA (IF 63.1) Pub Date : 2024-09-16 Zujin Luo,Yichong Li,Wenjun Li,Ying Li,Qingrong Nie,Yu Shi,Juan Wang,Qiuling Ji,Xuefeng Han,Sijie Liu,Dongmei Li,ShaSha Wang,Zhijun Li,Dong Jia,Huiqing Ge,Peifeng Xu,Zhijun Feng,Fengjie Li,Fucheng An,Na Tai,Lili Yue,Hongwei Xie,Xiuhong Jin,Hongru Liu,Qiang Dang,Yongxiang Zhang,Li Sun,Jinxiang Wang,He Huang,Liang Chen,Yingmin Ma,Zhixin Cao,Chen Wang,
Importance The effect of high-intensity noninvasive positive pressure ventilation (NPPV) on the need for endotracheal intubation in patients with an acute exacerbation of chronic obstructive pulmonary disease (COPD) is unknown. Objective To determine whether the use of high-intensity NPPV vs low-intensity NPPV reduces the need for endotracheal intubation in patients with an acute exacerbation of COPD
-
Combo COVID-19 and Flu mRNA Vaccine Falls Short of Total Flu Protection. JAMA (IF 63.1) Pub Date : 2024-09-13 Samantha Anderer
-
Study: Specific Inflammatory Biomarkers Linked to Mental Health Disorders. JAMA (IF 63.1) Pub Date : 2024-09-13 Samantha Anderer
-
Malaria Vaccine Candidate Could Prevent Infection During Pregnancy. JAMA (IF 63.1) Pub Date : 2024-09-13 Samantha Anderer
-
Expanded Medicare Coverage of Antiobesity Drugs May Cost Billions Each Year. JAMA (IF 63.1) Pub Date : 2024-09-13 Samantha Anderer
-
FDA Greenlights First At-Home Syphilis Test to Help Speed Up Diagnoses. JAMA (IF 63.1) Pub Date : 2024-09-13 Samantha Anderer
-
Twice-Yearly Doses of Azithromycin Past Infancy Cut Child Mortality. JAMA (IF 63.1) Pub Date : 2024-09-13 Samantha Anderer
-
Dialysis May Not Be Worth the Trade-Off for Older Adults. JAMA (IF 63.1) Pub Date : 2024-09-13 Samantha Anderer
-
Medicare Cuts Cost of 10 Common Drugs Covered by Part D. JAMA (IF 63.1) Pub Date : 2024-09-13 Samantha Anderer
-
Even After CPR, Surviving Out-of-Hospital Cardiac Arrest Might Be Influenced by Race, Sex JAMA (IF 63.1) Pub Date : 2024-09-13 Rita Rubin
This Medical News article discusses research that found Black individuals and women are less likely to survive after receiving cardiopulmonary resuscitation for out-of-hospital cardiac arrest than White people or men.
-
New Guidance Helps Clinicians Use Pemivibart to Protect Immunocompromised Patients From COVID-19 JAMA (IF 63.1) Pub Date : 2024-09-13 Anna Bock
This Medical News story discusses new guidelines for the use of pemivibart, a monoclonal antibody marketed as Pemgarda, as preexposure prophylaxis against COVID-19 in immunocompromised individuals.
-
Toward Understanding JAMA (IF 63.1) Pub Date : 2024-09-12 Charles McMahon
In this narrative medicine essay, a gastroenterologist learns of his 34-year-old brother’s stroke in Oslo and struggles to understand how such a young, healthy man could have a stroke while exercising.
-
State Biomarker Testing Insurance Coverage Laws. JAMA (IF 63.1) Pub Date : 2024-09-12 Lisa L Lacasse,Mark E Fleury,Hilary Gee Goeckner
-
Tenecteplase vs Alteplase for Patients With Acute Ischemic Stroke JAMA (IF 63.1) Pub Date : 2024-09-12 Xia Meng, Shuya Li, Hongguo Dai, Guozhi Lu, Weiwei Wang, Fengyuan Che, Yu Geng, Minghui Sun, Xiyan Li, Hao Li, Yongjun Wang
ImportanceTenecteplase is a bioengineered variant of alteplase with greater fibrin specificity and a longer half-life, allowing single-bolus administration. Evidence on the treatment effect of tenecteplase 0.25 mg/kg in Chinese patients with acute ischemic stroke (AIS) is limited.ObjectiveTo establish the noninferiority of tenecteplase to alteplase in patients with AIS within 4.5 hours of symptom onset
-
Cancer Stage vs Mortality End Points in Randomized Clinical Trials of Cancer Screening. JAMA (IF 63.1) Pub Date : 2024-09-12 Grace Y Kim,Peter Gibbs
-
Artificial Intelligence for Language Translation JAMA (IF 63.1) Pub Date : 2024-09-12 K. Casey Lion, Yu-Hsiang Lin, Theresa Kim
This Viewpoint discusses the challenges to implementing artificial intelligence–based translation in clinical settings and what health care organizations can do to mitigate these challenges.
-
Cancer Stage vs Mortality End Points in Randomized Clinical Trials of Cancer Screening. JAMA (IF 63.1) Pub Date : 2024-09-12 Tianyu Wang,Danxue He,Quanyong Yi
-
Cancer Stage vs Mortality End Points in Randomized Clinical Trials of Cancer Screening. JAMA (IF 63.1) Pub Date : 2024-09-12 Hilary A Robbins,Xiaoshuang Feng,Ruth Etzioni
-
State Biomarker Testing Insurance Coverage Laws-Reply. JAMA (IF 63.1) Pub Date : 2024-09-12 Grace A Lin,Janet M Coffman,Kathryn A Phillips
-
Evaluation of Suspected Antibiotic Allergies JAMA (IF 63.1) Pub Date : 2024-09-11 Ruchi Singla, Megan C. Elios, Andrew M. Davis
This JAMA Clinical Guidelines Synopsis summarizes the 2022 recommendations on evaluation of suspected antibiotic allergies from the American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma & Immunology.
-
Improving Palliative Care Access for Patients With Cancer. JAMA (IF 63.1) Pub Date : 2024-09-11 Eduardo Bruera
-
Medical Aid in Dying Laws: More Accessible in More States. JAMA (IF 63.1) Pub Date : 2024-09-11 Thaddeus Mason Pope
-
-
Is Medical Assistance in Dying Part of Palliative Care? JAMA (IF 63.1) Pub Date : 2024-09-11 Harvey Max Chochinov,Joseph J Fins
-
Tubal Sterilization Rates by State Abortion Laws After the Dobbs Decision JAMA (IF 63.1) Pub Date : 2024-09-11 Xiao Xu, Ling Chen, Vrunda B. Desai, Cary P. Gross, Craig Evan Pollack, Peter E. Schwartz, Jason D. Wright
This study examines whether the use of sterilization procedures changed after the Dobbs ruling by restrictiveness of state abortion laws.
-
Telehealth vs In-Person Early Palliative Care for Patients With Advanced Lung Cancer: A Multisite Randomized Clinical Trial. JAMA (IF 63.1) Pub Date : 2024-09-11 Joseph A Greer,Jennifer S Temel,Areej El-Jawahri,Simone Rinaldi,Mihir Kamdar,Elyse R Park,Nora K Horick,Kedie Pintro,Dustin J Rabideau,Lee Schwamm,Josephine Feliciano,Isaac Chua,Konstantinos Leventakos,Stacy M Fischer,Toby C Campbell,Michael W Rabow,Finly Zachariah,Laura C Hanson,Sara F Martin,Maria Silveira,Laura Shoemaker,Marie Bakitas,Jessica Bauman,Lori Spoozak,Carl Grey,Leslie Blackhall,Kimberly
Importance Numerous studies show that early palliative care improves quality of life and other key outcomes in patients with advanced cancer and their caregivers, although most lack access to this evidence-based model of care. Objective To evaluate whether delivering early palliative care via secure video vs in-person visits has an equivalent effect on quality of life in patients with advanced non-small
-
Pharmacy Benefit Manager Market Concentration for Prescriptions Filled at US Retail Pharmacies. JAMA (IF 63.1) Pub Date : 2024-09-10 Dima M Qato,Yugen Chen,Karen Van Nuys
-
Coding Error in Study of Risk Score Predicting Death Without Transplant in Adult Heart Transplant Candidates. JAMA (IF 63.1) Pub Date : 2024-09-09 Kevin C Zhang,William F Parker
-
Subsequent Smoking Cessation Treatment After Varenicline or Nicotine Replacement-Reply. JAMA (IF 63.1) Pub Date : 2024-09-09 Paul M Cinciripini